GT Biopharma Inc

-0.01 (-2.80%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

GT Biopharma Inc Stock, NASDAQ:GTBP

8000 Marina Boulevard, Suite 100, Brisbane, California 94005
United States of America
Phone: +1.415.919.4040
Number of Employees: 2


GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). Its product, GTB-3550, is initially developed for the treatment of AML and MDS, and other CD33+ hematologic cancers. GT Biopharma has worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE technology. The company was founded in 1965 and is headquartered in Brisbane, CA.